General Rules of Submission

There is NO LIMIT to the number of abstracts accepted. Each abstract must be submitted by the presenting author (submitter) in a suitable session.

Submission of an abstract implies that the presenting author has the consent of all authors and has obtained necessary institutional clearances.

Submission of an abstract acknowledges acceptance for the abstract to be published in the official abstract book of congress.

Authors are required to indicate their preference for oral or poster presentations by checking the appropriate box on the submission web page. The Scientific Committee, however, reserves the right to make the final decision on the mode of presentation.

All authors, especially non-native English speakers, are required to carefully check and review the English language to ensure the abstract meets English standards before submission.

The presenting author agrees to register, attend the congress and present the abstracts as scheduled. The abstract will be rejected if the presenting author does not register to attend the conference.

The Scientific Committee will review all submitted abstracts. The reviewing process is confidential and decisions are final.

Preparation of an Abstract

To submit your abstract to the 28th International Pig Veterinary Society Congress (IPVS 2026), please prepare your manuscript in MS Word (.doc or .docx) format according to the template of the IPVS 2026. Abstracts must be prepared single-spaced in Microsoft Word, using Times New Roman font at 12-point font size (except for 11-point size used in the abstract header and author information) and in only one A4 page (21.0 cm x 29.7 cm) with a left margin of 3 cm and the other margins of 2.5 cm.

Click here to download the official abstract template at MS Word form (.doc or .docx format) in accordance with the IPVS 2026 submission requirements.

The manuscript must include some main parts:

Title: Use a concise title that indicates the content of the abstract and is aligned in the center and placed in one single-spaced line below the abstract header. The complete title should be capitalized, bold and should not exceed 30 words. Refrain from using abbreviations in the title.

Author information (names and affiliations): Authors’ names should be centered and placed in one single-spaced line below the title. All names of authors should be listed (e.g., Trevor Editon Smith, Do Tien Duy, Nguyen Thanh Hai; only the first letter of the first, middle and last name is in the capital) and the presenting author is underlined.

Use superscript numbers to match individual authors with their corresponding affiliations. Institutional affiliations should include the department, university, city, state, or country (all with initial capital letters) and should be set in 11-point Times New Roman. They are centered and placed in a single-spaced line below the authors’ names, followed by the email address of the presenting author (the line “Email of corresponding author” needs to be italicized).

Abstract text: The abstract consists of no more than 350 words in only one A4 page. It begins after one blank line following the author’s information. It should be justified and not in bold. The abstract consists of some main parts (please see the provided template by clicking link here): Introduction and Objectives, Materials and Methods, Results and Discussion, and Conclusion. A single spacing between “Email of corresponding author” and “Introduction and Objectives” is required. Abstracts will be reproduced exactly as submitted and will not be edited in any way.

Keywords: The keywords begin after one blank line following the abstract text. The word “keywords” should be set in bold and aligned left. Provide up to 5 keywords. ONLY first letter of each keyword is UPPERCASE (unless a proper noun); keywords are separated by commas and presented in alphabetical order.

Acknowledgements (if any): Please provide a concise sentence to acknowledge funding sources, institutional support, or individuals who contributed to the work but are not listed as authors. If there are no acknowledgements, please leave this section blank.

References (if any): Please limit references to a maximum of 5. If there are no references, please leave this section blank.

Steps for Abstract Submission

Abstract Submission procedure includes eight main steps below:

  • Step 1: Click “Abstract submission” menu in the official of the IPVS 2026 at https://ipvs2026.vn/
  • Step 2: Click ”Submitting” button and “Start submitting your work here” button
  • Step 3: “Create an account”, update presenter’s information and login in
  • Step 4: Click “Your Submission/s” button
  • Step 5: Click “New submission” button
  • Step 6: Fill out all content in the abstract as required
  • Step 7: Click “Submit” button to complete your submission
  • Step 8: “Abstract submission confirmation” letter will be sent to you via email

Scientific Topics

Specify the scientific session to your abstract, pleases select the correct scientific sessions/topics with your abstract. However, according to the reviewers and scientific committee, your abstract might be change into other topics in the final decision. All manuscripts must be submitted using the online submission system available at below link with corresponding scientific sessions. Choose the correct scientific topics with your abstract:

  • No. 1 Virology and Viral Diseases (VVD) [2 sessions]

This session is for updated publications to explore the latest developments and update the latest cutting-edge scientific achievements in virology and viral disease research, focusing on important viruses, transmission dynamics, and innovative therapeutic strategies associated with pig industry. Some of the relevant key topics highlighted are as follows: Advancements in swine virology and viral diseases; Evolution and re-emerging swine viral pathogens; Advancements in swine viral disease diagnostics; Zoonotic potential of swine viruses; Important viral diseases and global surveillance.

  • No. 2 Bacterial and Parasitic Diseases (BPD)

This session is for updated publications on strategies in combating bacterial and parasitic diseases, focusing on their impact on global health and innovative solutions for prevention and treatment associated with the pig industry. Some of the relevant key topics highlighted are as follows: Advancements in swine parasitology and parasitic diseases; Important and emerging bacterial diseases in swine; Antimicrobial resistance in swine pathogens; Biosecurity measures for bacterial and parasitic disease control; and Novel therapeutic approaches.

  • No. 3 Combating African Swine Fever (ASF)

This session is for updated publications on advances in potential research, application, innovation and strategies for combating African Swine Fever. Some of the relevant key topics highlighted are as follows: Exploring breakthroughs, challenges, and global implications; Current status, Case studies, ASF vaccine trials and applications, and future prospects of ASF vaccine development; Exploring regional and global collaboration for ASF control.

  • No. 4 Emerging Diseases in Swine (EDS)

This session is for updated publications on emerging infectious diseases in the swine industry. Some of the relevant key topics highlighted are as follows: Surveillance, prevention, and control measures for new and re-emerging diseases; Lessons learned from past outbreaks: Prevention and control; Zoonotic threats from swine diseases; and Strengthening biosecurity measures at farm and regional levels.

  • No. 5 Advancements in Immunology and Vaccination (AIV) [2 sessions]

This session is for updated publications on immune system mechanisms, novel vaccine technologies, global vaccination strategies, and the role of immunization in preventing current swine popular diseases. Some of the relevant key topics highlighted are as follows: Advancements in swine vaccines; Novel vaccine technologies for swine diseases; Impact of vaccination on virus evolution; and Swine immune system and disease resistance.

  • No. 6 Herd Health Management (HHM) [2 sessions]
This session is for updated publications on the latest strategies, practices and cutting-edge scientific achievements to maintain the well-being of livestock populations, providing insights into herd health management practices in the pig production system. Some of the relevant key topics highlighted are as follows: Preventive health programs; Reproductive health management; Housing and environmental management; Record-keeping and health monitoring; Disease diagnosis and treatment.
  • No. 7 Pig Production and Sustainability (PPS)
This session is for updated publications on the recent advances and the latest cutting-edge scientific achievements in pig production and sustainability. Some of the relevant key topics highlighted are as follows: Genetic improvements in swine (advances in genomics for disease resistance and productivity); Climate change and its impact on pig farming (adapting to environmental challenges); and Economic and policy challenges in global pig production (Navigating trade, regulations, and market dynamics).
  • No. 8 AIoT in Pig Health and Production (AIoT)
This session is for updated publications on the transformative role of artificial intelligence of things (AIoT) in enhancing disease detection, improving farm management, and optimizing the overall health and productivity of pigs on the farm. Some of the relevant key topics highlighted are as follows: Precision livestock farming (leveraging technology for monitoring pig health, welfare, and productivity); AI-driven disease prediction and management (AI in pig welfare monitoring, automation in swine farming, AI for genetic optimization, and Big data and AI integration).
  • No. 9 Nutrition and Gut Microbiota (NGM) [2 sessions]
This session is for updated publications on the recent advances and innovations in feeding strategies, nutrient optimization, feed formulation, gut microbiota and sustainable practices in the swine industry. Some of the relevant key topics highlighted are as follows: Gut microbiota and nutrition (the role of diet in pig health and growth); Alternative protein sources for feed (Exploring sustainable and cost-effective options).
  • No. 10 Onehealth, AMR and Pig Welfare (OAW)
This session is for updated publications on the relationships/interconnectedness of human, animal, and environmental health, as well as antimicrobial resistance (AMR), emphasizing integrated approaches to improve pig welfare, disease prevention, and sustainable farming practices. Some of the relevant key topics highlighted are as follows: Antimicrobial resistance in swine production (strategies for responsible drug use and combating resistance); Pig welfare and behavioral studies (enhancing welfare through better housing and management practices).
  • No. 11 Reproduction Technologies and Lactation (RTL)

This session is for updated publications on reproduction and lactation aspects in the swine industry. Some of the relevant key topics highlighted are as follows: Innovations in breeding and fertility management (advances in artificial insemination and embryo transfer, genetic tools for improving reproductive performance, managing reproductive disorders in breeding sows, and ethical considerations in reproductive technologies).

  • No. 12 Pig Farming Practice (PFP)

This session is for updated publications on advances and updated technologies in pig farming, focusing on animal sustainability, biosecurity, and improving production efficiency. Some of the relevant key topics highlighted are as follows: Sustainable pig farming practices (balancing productivity with environmental sustainability, reducing greenhouse gas emissions in pig production, waste management solutions, water saving practices in pig farming, balancing animal welfare and environmental sustainability).

No. Scientific Topics Description
1 Virology and Viral Diseases (VVD)

[2 sessions]

This session is for updated publications to explore the latest developments in virology and viral disease research, focusing on important viruses, transmission dynamics, and innovative therapeutic strategies associated with the pig industry.

Some of the relevant key topics highlighted are as follows: Advancements in swine virology and viral diseases; Evolution and re-emerging swine viral pathogens; Advancements in swine viral disease diagnostics; Zoonotic potential of swine viruses; Important viral diseases and global surveillance.

2 Bacterial and Parasitic Diseases (BPD) This session is for updated publications on strategies in combating bacterial and parasitic diseases, focusing on their impact on global health and innovative solutions for prevention and treatment associated with the pig industry.

Some of the relevant key topics highlighted are as follows: Advancements in swine parasitology and parasitic diseases; Important and emerging bacterial diseases in swine; Antimicrobial resistance in swine pathogens; Biosecurity measures for bacterial and parasitic disease control; and Novel therapeutic approaches.

3 Combating African Swine Fever (ASF) This session is for updated publications on advances in potential research, application, innovation and strategies for combating African Swine Fever.

Some of the relevant key topics highlighted are as follows: Exploring breakthroughs, challenges, and global implications; Current status, Case studies, ASF vaccine trials and applications, and future prospects of ASF vaccine development; Exploring regional and global collaboration for ASF control.

4 Emerging Diseases in Swine (EDS) This session is for updated publications on emerging infectious diseases in the swine industry. Some of the relevant key topics highlighted are as follows: Surveillance, prevention, and control measures for new and re-emerging diseases; Lessons learned from past outbreaks: Prevention and control; Zoonotic threats from swine diseases; and Strengthening biosecurity measures at farm and regional levels.
5 Advancements in Immunology and Vaccination (AIV)

[2 sessions]

This session is for updated publications on immune system mechanisms, novel vaccine technologies, global vaccination strategies, and the role of immunization in preventing current swine popular diseases. Some of the relevant key topics highlighted are as follows: Advancements in swine vaccines; Novel vaccine technologies for swine diseases; Impact of vaccination on virus evolution; and Swine immune system and disease resistance.
6 Herd Health Management (HHM)

[2 sessions]

This session is for updated publications on the latest strategies, practices and cutting-edge scientific achievements to maintain the well-being of livestock populations, providing insights into herd health management practices in the pig production system. Some of the relevant key topics highlighted are as follows: Preventive health programs; Reproductive health management; Housing and environmental management; Record-keeping and health monitoring; Disease diagnosis and treatment.
7 Pig Production and Sustainability (PPS) This session is for updated publications on the recent advances and the latest cutting-edge scientific achievements in pig production and sustainability. Some of the relevant key topics highlighted are as follows: Genetic improvements in swine (advances in genomics for disease resistance and productivity); Climate change and its impact on pig farming (adapting to environmental challenges); and Economic and policy challenges in global pig production (Navigating trade, regulations, and market dynamics).
8 AIoT in Pig Health and Production (AIoT) This session is for updated publications on the transformative role of artificial intelligence of things (AIoT) in enhancing disease detection, improving farm management, and optimizing the overall health and productivity of pigs on the farm. Some of the relevant key topics highlighted are as follows: Precision livestock farming (leveraging technology for monitoring pig health, welfare, and productivity); AI-driven disease prediction and management (AI in pig welfare monitoring, automation in swine farming, AI for genetic optimization, and Big data and AI integration).
9 Nutrition and Gut Microbiota (NGM)

[2 sessions]

This session is for updated publications on the recent advances and innovations in feeding strategies, nutrient optimization, feed formulation, gut microbiota and sustainable practices in the swine industry. Some of the relevant key topics highlighted are as follows: Gut microbiota and nutrition (the role of diet in pig health and growth); Alternative protein sources for feed (Exploring sustainable and cost-effective options).
10 Onehealth, AMR and Pig Welfare (OAW) This session is for updated publications on the relationships/interconnectedness of human, animal, and environmental health, as well as antimicrobial resistance (AMR), emphasizing integrated approaches to improve pig welfare, disease prevention, and sustainable farming practices. Some of the relevant key topics highlighted are as follows: Antimicrobial resistance in swine production (strategies for responsible drug use and combating resistance); Pig welfare and behavioral studies (enhancing welfare through better housing and management practices).
11 Reproduction Technologies and Lactation (RTL) This session is for updated publications on reproduction and lactation aspects in the swine industry. Some of the relevant key topics highlighted are as follows: Innovations in breeding and fertility management (advances in artificial insemination and embryo transfer, genetic tools for improving reproductive performance, managing reproductive disorders in breeding sows, and ethical considerations in reproductive technologies).
12 Pig Farming Practice (PFP) This session is for updated publications on advances and updated technologies in pig farming, focusing on animal sustainability, biosecurity, and improving production efficiency. Some of the relevant key topics highlighted are as follows: Sustainable pig farming practices (balancing productivity with environmental sustainability, reducing greenhouse gas emissions in pig production, waste management solutions, water saving practices in pig farming, balancing animal welfare and environmental sustainability).

Peer Review Process

Generally, all submitted manuscripts will be carefully reviewed by assigned reviewers by The Scientific Committee/Editor-in-Chief through several steps (below-provided editorial workflow) for final decision to have the best-qualified abstract.

Criteria for selection of abstracts

The accepted manuscripts need to meet the following criteria:

(1). Relevance to the IPVS 2026 Conference Theme

– It should be aligned with the main topics or focus areas of the IPVS 2026.

– It needs to be innovative, or addressing a key challenge in the field associated with the IPVS 2026.

(2). Scientific and Technical Quality

– It must be a kind of academic manuscript (not commercial one as advertisements for commercial products) containing rigour Scientific level.

– It requires to have the sound and appropriate methodology.

– It needs to be stated clearly the objectives.

– The results or figures need to be credible, measurable, and well-explained.

(3). Originality and Novelty

– Scientific logic, integrity and coherence

– It needs to present new data and ideas with previous publications

– It ensures to not overlap with previous studies in terms of data and content

(4). Clarity and Structure

– It requires a well-written abstract with logical flow.

– It needs to be corrected format as the IPVS 2026 guideline.

(5) Significance and Impact

– It needs to have practical implications, and scientific contribution to the targeted field of the IPVS 2026.

->The evaluation follows a 5-point scoring system for each criterion (Table 1). For each criterion, a score of 1 indicates insufficient, 2 indicates fair, 3 denotes good, 4 represents very good, and 5 reflects excellent performance.

To be accepted for presentation at the IPVS 2026 Conference, an abstract must obtain a minimum average score of 3, or all evaluation criteria must receive a score at 3 or higher.

Table 1. Scoring the manuscript based on each criterion

If you have any questions or for further information, please feel free to contact the Scientific Committee:

  • Via email: abstract@ipvs2026.vn
  • Prof. Dr. Do Tien Duy (The Congress secretariat and Deputy Head of the Scientific Committee; Vice Head of the Scientific Research Management Office, Nong Lam University HCMC). Mobile phone: (+84) 918.356.744, Email: duy.dotien@hcmuaf.edu.vn.
  • Dr. Nguyen Thanh Hai (Secretariat of the Scientific Committee, IPVS 2026). Mobile phone: (+84) 973.329.653, Email: hai.nguyenthanh@hcmuaf.edu.vn.

Thank you for your valuable contribution.

We look forward to welcoming you to the IPVS 2026 in Ho Chi Minh City, Vietnam.

Sincerely Yours,
The Scientific Committee,
The Organizing Committee of IPVS 2026,
Ho Chi Minh City, Vietnam.